January 2025 Newsletter

Welcome to the monthly Crown Bioscience newsletter. Discover some of our monthly highlights to keep up to date with recent developments and to learn more about our services. Don't forget to follow us on LinkedIn to avoid missing our daily updates!

We're proud to be the recipient of the BioTech Breakthrough Award in the Biopharma category for our innovation in drug development. This prestigious award highlights the achievements of our OrganoidXplore? screening platform in advancing preclinical and translational oncology research.

OrganoidXplore has emerged as the leading organoid panel screening service by processing more than 100 oncology models in six weeks, significantly expediting the drug development process with its rapid, data-driven decision-making capabilities.

See how multi-omics data and in silico techniques turn complex datasets into impactful biomarkers, helping you make informed, patient-centered decisions for? personalized therapy.

Gain practical guidance on designing and executing PDX mouse clinical trials (MCTs) that reflect the heterogeneity of human populations, leading to more relevant and actionable results.

From leveraging multi-omics data to designing personalized treatment regimens, data science and bioinformatics are vital. Here’s a deep dive into how these technologies are reshaping the field.

As ADC development continues to accelerate, our latest data and capabilities are available to help researchers and developers like you to optimize your ADC programs.

Using patient-derived organoids (PDOs) will transform your drug development. Our free White Paper shows improved timelines, scalability, and biomarker discovery. Get you free copy today.

Our Multi-omics Grade biospecimens ensure excellent sample quality with the lowest ischemia time possible. Choose your samples online and excel in your research.

? 2025 Crown Bioscience

Crown Bioscience, Inc. 16550 West Bernardo Drive, Building 5, Suite 525, San Diego, CA 92127, United States